Smartwatch-Guided exercise may tame pregnancy risks

NCT ID NCT07678944

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study investigates whether a structured, personalized exercise plan—tracked with a smartwatch and supported by regular phone check-ins—can help control blood sugar, blood pressure, and weight gain in pregnant women with gestational diabetes, chronic hypertension, or obesity. Researchers compare outcomes between women who follow the exercise guidelines and those who do not. The goal is to see if this approach reduces complications like preterm birth and low birth weight.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
personalized exercise prescription with smartwatch monitoring
What this could lead to
If effective, this approach could offer a drug-free way to manage complications like gestational diabetes and hypertension during pregnancy, improving outcomes for both mother and baby.
What could go wrong
This is a single-arm study without a control group, so results may be influenced by other factors. Adherence to exercise may vary, and the findings may not apply to all pregnant women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ULSCoimbra

    Coimbra, Coimbra District, 3004-561, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.